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Abstract We report an unusual case of epithelioid
sarcoma. The tumour occurred in the finger of a 27-
year-old female. The clinical history, histology and the
electron microscopy of the lesion were typical for
epithelioid sarcoma. However, immunohistochemical
analysis showed strong membranous CD31 staining, a
finding hitherto not described. All other robust vascular
markers, including factor-VIII-related antigen (FVIIIrag)
were negative. The findings were compared with the
available literature data, leading us to conclude that there
is insufficient evidence for endothelial derivation of
epithelioid sarcoma, but in the differential diagnosis with
vascular tumours CD31 may stain and to rule out
angiosarcoma FVIIIrag is a useful antibody.
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Introduction
Epithelioid sarcoma (ES) is a rare but distinctive soft
tissue tumour, which most frequently arises in the
extremities of young individuals [3, 5]. The classical
type of ES often presents as a cutaneous lesion and may
be mistaken for a benign process. Histologically, ES is
composed of nodular aggregates of monomorphic inter-
mediate sized cells often with eccentrically placed nuclei
and deeply eosinophilic cytoplasm, imparting a rhabdoid
appearance to the tumour cells. Epithelioid sarcoma
tumour nodules frequently form granulomatous struc-
tures, which may have central necrosis. The differential
diagnosis of ES includes carcinoma and epithelioid
mesenchymal tumours. Cutaneous epithelioid angiosar-
coma and the recently described tumour epithelioid
sarcoma-like hemangioendothelioma (ES-H) are often
considered on morphological grounds. In particular ES-H,
which shares considerable morphological and immuno-
histochemical overlap with classical ES needs to be
differentiated [2]. In ES, immunoreactivity for cytokeratin
and epithelial membrane antigen (EMA) is almost
invariably present. CD34 staining, present in most cases
of ES, is valuable in ruling out carcinoma. The CD31
marker is often quoted as useful when distinguishing
between epithelioid sarcoma and epithelioid angiosarco-
ma but is positive in ES-H. Although CD31 expression
has been described in ES, it is reported as focal and non-
membranous. We report a case of epithelioid sarcoma
with typical clinical and morphological features but with
unusual immunohistochemical findings.
Clinical history
A 27-year-old female presented with an ill-defined mass
in the soft tissue of the middle phalanx of the fourth finger
of the right hand, which had slowly increased in size in a
period of 3 years. The clinical impression raised the
possibility of a giant cell tumour. An excisional biopsy
was initially diagnosed as an inflammatory granuloma-
tous lesion. However, the lesion recurred shortly after
removal with ulceration of the skin. Histological review
of the original specimen revealed histological findings in
keeping with an ES. The finger was subsequently
amputated in continuity with the metacarpal bone and
submitted for pathological evaluation.
Materials and methods
The amputation specimen was submitted fresh; tumour tissue was
reserved for frozen sections and small samples were placed in
formalin—glutaraldehyde for electron microscopy (EM). Routine
histological haematoxylin and eosin (H&E) stained sections from
formalin-fixed paraffin-embedded tissue were prepared and, in
M. A. den Bakker ()) · M. Kliffen
Department of Pathology, Erasmus Medical Center,
PO Box 1738, 3000 DR Rotterdam, Netherlands
e-mail: m.denbakker@erasmusmc.nl
Tel.: +31-10-4087901, Fax: +31-10-4089487
S. J. Flood
Department of Plastic and Reconstructive Surgery,
Erasmus MC, Rotterdam, Netherlands
addition, PAS and reticulin stains were prepared from selected
blocks. Immunohistochemistochemistry was performed in an
automated immunostainer on paraffin-embedded tissue and on
acetone-fixed cryostat sections, using a polymer based system
(Dako Envision, Dako, Glostrup, Denmark; Table 1)
Pathological findings
A nodular and ulcerated area was seen in soft tissues and
skin of the middle phalanx, over an area of approximately
1.51 cm, extending over the dorsal, lateral and ventral
regions (Fig. 1). Grey, shiny firm tissue was seen
extending from the ulcerated surface down to the bone
but without macroscopic invasion of the tendon or bone.
The borders were ill defined; lesional tissue did not
appear to involve the joint capsule.
The histology of the excisional biopsy and the
amputation specimen were similar. A diffuse and nodular,
focally granulomatous appearing lesion composed of
intermediate sized cells was seen embedded in collage-
nous stroma and infiltrating diffusely in muscle and
connective tissue. Angio-invasion was clearly present.
The cells formed a monotonous population with many
rhabdoid cells. Typical “granulomatous” structures with
central necrosis were present (Fig. 2A). Fascicular areas
were not observed and the cellular composition was
exclusively epithelioid in nature.
Immunohistochemical staining
The immunohistochemical results are summarised in
Table 1. The tumour cells showed intense staining with
cytokeratin antibodies AE1/AE3, NCL5D3 (cytokeratins
8, 18) and cytokeratin 19 (Fig. 2B). Strong EMA staining
was seen and the tumour cells expressed CD34 (Fig. 2C)
and CD99 with a membranous pattern. Surprisingly, in
the biopsy, all tumour cells stained strongly with CD31
antibodies. The staining pattern was membranous and
consistent throughout the sample (Fig. 2D). In the
amputation specimen, the staining was more variable.
However, most tumour cells were positive again with
membranous staining. Additional vascular markers were
tested, including PAL-E, CD146, factor-VIII-related
antigen (FVIIIrag), vascular endothelial growth factor
(VEGF), VEGF receptors 1 and 2 and thrombomodulin,
these were all negative. Nuclear staining of varying
intensity was seen in Fli-1 immunostaining.
Table 1 Immunohistochemical reagents and staining results. Tis-
sue: P paraffin, F frozen. Pre-treatment: w wet heat antigen
retrieval, pr protease digestion. Result: ++ strong universal
staining, + focal staining, variable intensity,  no staining, m
membranous, c cytoplasmic, n nuclear
Antibody (clone) Manufacturer Tissue,
pretreatment
Dilution Result
Cytokeratin 8,18 (NCL5D3) Biogenex, San Ramon, California, USA P, pr 1:100 ++ c
Pancytokeratin (AE1/AE3) Biogenex P, w 1:100 ++ c
Cytokeratin 19 (RCK108) Euro-diagnostica, Arnhem, Netherlands P, w 1:20 ++ c
EMA (E29) Dako, Glostrup, Denmark P,w 1:2000 ++ c
Desmin (D33) Dako P, w 1:400 
Muscle actin (HHF35) Dako P, w 1:400 + c
Vimentin (V9) Dako P, w 1:3200 ++ c
S100 (rabbit polyclonal) Dako P, – 1:2000 
p53 (D-O7) Dako P, w 1:1000 + n
CD99 (12E7) Dako P, w 1:100 ++ m
CD31 (JC70A) Dako P, w 1:240 ++ m
FVIIIrag (2C8) Dako P, pr 1:1000 
CD34 (QBEnd10) Dako P, w 1:100 ++ m
Fli-1 (polyclonal) Santa Cruz Biotechnology Inc. Santa Cruz, California, USA P, w 1:50 +n
EGF-R (H11) Dako F 1:80 ++ m
VEGF-R1 (Flt-19) Sigma, Saint Louis, Missouri, USA F 1:80 
VEGF-R2 (KDR-1) Sigma F 1:400 
VEGF (JH121) Oncogene Research Products, San Diego, California, USA F 1:20 
Thrombospondin (46.4) Oncogene Research Products F 1:320 
CD146 (P1H12) Chemicon International Inc. Temecula, California, USA F 1:100 
PAL-E Monosan, Sanbio, Uden, Netherlands F 1:80 
Fig. 1 Amputation specimen with ulcero-nodular lesions over the
mid-phalanx
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Electron microscopy
Compact perinuclear whorled aggregates of filaments
were seen in many cells. Well-formed desmosomes were
easily identified (Fig. 3). Weibel-Palade bodies were not
observed.
Discussion
Epithelioid sarcoma is a unique soft tissue tumour of
which the origin is not clear. Two distinct subtypes have
been described. The classical form typically occurs in the
superficial soft tissues of the distal parts of the extremities
[3, 5]. A recently described second form, designated the
proximal type of ES, tends to occur in deeper soft tissue
of the limb girdles [9, 10]. The long-term prognosis of ES
is poor, with local recurrences preceding distant metas-
tases [3]. The typical histological appearance of ES
consists of aggregates of monomorphic cells with well-
defined cell boundaries and little nuclear pleomorphism.
The cytoplasm is eosinophilic and often imparts a
rhabdoid appearance to the cells, which on the ultrastruc-
Fig 2 Light microscopy (amputation specimen). A Granulomatous
structure with central necrosis formed by rhabdoid tumour cells
(lower inset), occasionally with cytoplasmic vacuolisation (upper
inset) (H&E staining, 100, insets 400 magnification). B Immu-
nohistochemical staining for cytokeratin 19, cytoplasmic staining is
seen (100 magnification). C CD34 staining. Intense membranous
staining is present (100 magnification). D Immunohistochemical
staining for CD31 shows distinct membranous staining (100
magnification)
Fig. 3 Electron microscopy. Compact peri-nuclear whorls of
intermediate filaments are seen. Inset Desmosomes were easily
identified in the tumour
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tural level is caused by peri-nuclear aggregates of
filaments. A characteristic feature of ES is areas mim-
icking granulomas, often with central necrosis. Cytoplas-
mic vacuoles and pseudo-vascular spaces may be seen in
ES raising the differential diagnostic possibility of an
(epithelioid) vascular lesion sometimes referred to as
“angiomatoid ES” [3, 5, 9, 20, 21]. Immunohistochemical
findings in ES include staining with epithelial markers
such as EMA or cytokeratins and CD34. The latter marker
is very useful to rule out metastatic carcinoma. However,
in differentiating ES from angiosarcoma, CD34 staining
cannot discriminate and, in addition, cytokeratin staining
is well recognised in epithelioid angiosarcoma. Although
EMA staining is unusual in angiosarcoma, this too has
been described [7, 12]. Antibodies to the CD31 antigen
PECAM (platelet endothelial cell adhesion molecule) are
deemed to be highly specific vascular markers and are
often used to mark endothelial derived tumours [4, 14]. In
keeping with the nature of PECAM as an adhesion
molecule, specific staining by CD31 is membranous. In
the case we describe here, strong and consistent mem-
branous CD31 staining was seen in the biopsy specimen
and the resection specimen. Weak CD31 immunoreactiv-
ity was observed in five of 70 (7%) typical ESs and two of
eight angiomatoid ESs in a large series by Miettinen et al.
[15]. Other workers have also described positive CD31
staining in peripheral ES in a small percentage of cases
[17, 18]. However, in the proximal type CD31 is reported
as negative [9, 10]. In all published reports with positive
CD31 staining in ES it has been focal and cytoplasmic,
not membranous. Because of this unusual finding, we
extended our panel of antibodies to include other
recognised vascular markers (Table 1). With the excep-
tion of Fli-1, a recently described marker of vascular
endothelium, no staining was observed [8]. In particular
FVIIIrag staining was completely negative. This is
consistent with data from the literature where FVIIIrag
staining in ES has not been described [1, 3, 9, 11, 15, 18,
19, 21]. A close mimic of ES was recently described by
Billings et al. [2]. These authors report on seven cases of a
novel vascular tumour entity, which show markedly
overlapping features with ES. Due to the absence of
metastases indicating low-grade behaviour, it is suggested
that this tumour is a new form of hemangioendothelioma
for which the name epithelioid sarcoma-like hemangio-
endothelioma (ES-H) is coined. The clinical presentation
and architecture of ES-H is similar to classical ES,
although a fascicular and sheet-like growth pattern was
also noted, which is not typical for ES. Although the
authors note that the cells of ES-H have an epithelioid
shape with prominent eosinophilic cytoplasm, they do not
describe the typical rhabdoid inclusions, which charac-
terise classical ES, caused by the perinuclear condensa-
tion of intermediate filaments. Similar to true vascular
neoplasms, ES often has intracytoplasmic lumina, as we
describe in the case presented here. In the cases of ES-H,
this was an infrequent finding and may be a useful
morphological clue when distinguishing these entities.
Remarkably, all six cases of ES-H that were analysed
immunohistochemically were positive for CD31 (mem-
branous pattern) and for Fli-1 (nuclear) but did not stain
for CD34. These observations support an endothelial
derivation of this tumour and are similar to the results of
the ES case presented here. The Fli-1 antibody is highly
specific for Ewing sarcoma and in a single study was
found to be a specific marker for endothelium-derived
tumours. However, it also stains a small number of non-
vascular tumours. At this time, there is not enough
experience with this antibody to comment on its use in
epithelioid sarcoma [8]. Although the initial series of
ES-H is small, CD34 may still serve as a distinguishing
immunostain as all cases of ES-H were negative. Unfor-
tunately, EM was not performed on the ES-H cases. The
presence of Weibel-Palade bodies and pinocytic vesicles
would have strengthened the case for a vascular origin of
ES-H. In our case presented here, electron microscopy did
not reveal features suggesting endothelial differentiation
and were otherwise consistent with ES with perinuclear
whorls of intermediate filaments and desmosomes [6, 9,
13, 16]. It is noted that immunohistochemistry has a
critical role in distinguishing ES- and ES-H and that
CD31 and Fli-1 are important discriminators [2]. We thus
conclude that the case of ES described here is highly
unusual in its immunohistochemical profile and because
of its distinctive CD31 staining and Fli-1 positivity could
be mistaken for an angiosarcoma or for the newly
described ES-H [2]. However, the morphological features,
EM findings and CD34 positivity permit a confident
diagnosis of ES. In cases where the differential diagnosis
includes ES-H and angiosarcoma, careful attention should
be paid to distinguishing morphological features. Addi-
tion of FVIIIrag to an immunohistochemical panel in
cases where the differential diagnosis includes angiosar-
coma is indicated.
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